Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,000
Total Value
$632,866.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 2, 2026 | Sale | 5,900 | $41.73 | $246,207.00 | 651,640 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 9,100 | $42.49 | $386,659.00 | 642,540 | Direct | โ | View Details |